The case for medicines as major consumer products over the next 20 years

A post predicts medicines could become some of the biggest consumer products over the next 20 years, citing demand for tirzepatide, which it says generates more revenue than Netflix. It argues AI-assisted research, new biological tools and regulatory changes could expand what drugmakers can build. But the author sees drug development as the bigger uncertainty: establishing long-term safety takes time, and promising treatments can fail in large trials.